Ureteroscopic Laser Modality on Total Lasing Time and Total Energy in Patients With Large, Dense Renal Calculi

May 12, 2023 updated by: Luay, Albany Medical College
This study will examine the effects of ureteroscopic lasing technique (dusting, fragmentation and a hybrid approach) on total lasing time and total energy in patients with a large renal calculi burden of single or multiple stones with the sum of its longest diameters between 10-20 mm and having mean Hounsfield units of 1000 or more.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This study will examine the effects of ureteroscopic lasing technique (dusting, fragmentation and a hybrid approach) on total lasing time and total energy in patients with a large renal calculi burden of single or multiple stones with the sum of its longest diameters between 10-20 mm and having mean Hounsfield units of 1000 or more. Additionally, we will observe the impact of these parameters on total operative time.

Study Type

Interventional

Enrollment (Anticipated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • New York
      • Albany, New York, United States, 12208
        • Recruiting
        • Albany Medical College
        • Contact:
        • Contact:
        • Principal Investigator:
          • Luay Alshara, MD
        • Sub-Investigator:
          • Mark White, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adults between the ages of 18-80.
  • Any gender, race or ethnicity may be included- these factors play a small, if any role on renal calculi formation and ability to withstand procedure.
  • Must be suitable for a flexible ureteroscopy as determined by the MD
  • Large renal calculi burden of single or multiple stones with the sum of its longest diameters between 10-20 mm
  • An average stone density of at least 1000 Hounsfield units.

Exclusion Criteria:

  • Those with a stone burden less than 10mm or more than 20mm.
  • Those with an average stone density below 1000 Hounsfield units.
  • Patients who are dependent on mandatory anticoagulation therapies and cannot stop for surgery
  • Patients that cannot undergo ureteral access sheath placement
  • Patients with abnormal anatomy such as horseshoe kidney
  • Patients with a history of:

    • Ipsilateral upper urinary tract reconstructive procedures on the side of the renal calculi
    • Ipsilateral ureteral strictures
    • Prior radiotherapy of the abdomen or pelvis
    • Neurogenic bladder
    • Spinal cord injuries
    • Those who are pregnant
    • Currently being treated for infection or cancer

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Flexible Ureteroscopy with Dusting
Flexible ureteroscopy with the dusting lasing technique. MOSES parameters will be set to an energy of 0.3-0.4 Jules and a frequency of 50-80 hertz
A holmium laser technology widely used as the gold standard for laser lithotripsy for ureteroscopy treatment of renal calculi,
Other: Flexible Ureteroscopy with Fragmentation
Flexible ureteroscopy utilizing the Fragmentation lasing technique. MOSES parameters will be set to 0.8-1 JULES and a frequency of 8-10 hertz
A holmium laser technology widely used as the gold standard for laser lithotripsy for ureteroscopy treatment of renal calculi,
Other: Flexible Ureteroscopy with Hybrid
Flexible ureteroscopy utilizing the Hybrid lasing technique which will use both sets of parameters.
A holmium laser technology widely used as the gold standard for laser lithotripsy for ureteroscopy treatment of renal calculi,

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reduced OR time
Time Frame: 2 hours
Hybrid technique will result in overall reduced OR time
2 hours
Less Energy Transmission to Patient
Time Frame: 2 hours
Hybrid technique will have less energy transmission to the patient
2 hours

Secondary Outcome Measures

Outcome Measure
Time Frame
Stone Free
Time Frame: 1 month after surgery
1 month after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 22, 2023

Primary Completion (Anticipated)

February 1, 2025

Study Completion (Anticipated)

August 1, 2025

Study Registration Dates

First Submitted

May 12, 2023

First Submitted That Met QC Criteria

May 12, 2023

First Posted (Actual)

May 22, 2023

Study Record Updates

Last Update Posted (Actual)

May 22, 2023

Last Update Submitted That Met QC Criteria

May 12, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Renal Calculi

Clinical Trials on MOSES laser system

3
Subscribe